Few traders may realize it, but OrganiGram Holdings Inc (OTCMKTS:OGRMF) has been one of the most productive positions in the cannabis theme over the past 3 years, moving from about $0.15/share to over $6/share in a steady trend with no major drawdowns. To help further that narrative, the company just unveiled its Trailblazer line, the newest addition to their portfolio of products ready for the launch of the adult use recreational cannabis market in Canada.
According to the release, Trailblazer was developed in rapid response to ongoing discussions with Organigram’s jurisdictional and retail partners across Canada and their focus on offering high-value offerings. “Our brand strategy is creative and thoughtful, based on a concerted effort to wholly understand our current and future customers,” explains Ray Gracewood, Chief Commercial Officer, Organigram.
OrganiGram Holdings Inc (OTCMKTS:OGRMF) casts itself as a company that produces and sells medical marijuana in Canada. The company was founded in 2013 and is based in Moncton, Canada.
According to company materials, OrganiGram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, OrganiGram Inc., is a licensed producer of medical marijuana in Canada. OrganiGram is focused on producing the highest quality, condition-specific medical marijuana for patients in Canada.
OGRMF’s facility is located in Moncton, New Brunswick and the Company is regulated by the Access to Cannabis for Medical Purposes Regulations.
According to company materials, “From the day we started back in 2013, it’s been about making lives better – for our clients, our people, and our community. We’re based in Moncton, New Brunswick, the heart of the Maritimes, but at OrganiGram Holdings we’re committed to improving the quality of life for Canadians across the country. For us, this means working with health-care providers and industry organizations, supporting research and education, and providing a safe, effective product. To be effective in that last goal, we made a decision to produce organic cannabis. Growing certified organic medical cannabis isn’t easy, in fact, most licensed producers won’t take this on. It means more care, more testing, more rules… but in the end, it means a product that we feel delivers on our goals in the best way. And improving the quality of life for Canadians is not just about getting safe, quality product to them effectively. It’s about creating jobs, being good neighbors and contributing to our community.”
Find out when $OGRMF reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, the company just unveiled its Trailblazer line, the newest addition to their portfolio of products ready for the launch of the adult use recreational cannabis market in Canada. In all, we’ve witnessed 7% added to share values of the listing over the past month of action. What’s more, the name has seen a growing influx of trading interest, with the stock’s recent average trading volume running a bit less than 190% above the average volume levels in play in this stock over the longer term.
“We always want to be nimble enough to respond to what our partners need. Across the country, the message has been clear that a high value, quality product is an important consideration for customers and an effective tool to help combat the black market for cannabis. Trailblazer delivers on both those fronts. The brand concept behind Trailblazer is a celebration of the end of prohibition,” Gracewood says.
“Forging the path to legalization has taken many years of hard work by citizens, industry and government, but here we are on the verge of a legal, adult recreational market in Canada in 2018. The brand is a celebration of that effort and a reminder to always blaze your own trail.”
Earning a current market cap value of $675.74M, OGRMF has a significant war chest ($155.8M) of cash on the books, which compares with about $9.1M in total current liabilities. OGRMF is pulling in trailing 12-month revenues of $12.2M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 94.3%. We will update the story again soon as developments transpire. Sign-up for continuing coverage on shares of $OGRMF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $OGRMF, either long or short, and we have not been compensated for this article.